Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Vivacit-E Post-market Follow-up Study

NCT: NCT03226808 · COMPLETED

NCT IDNCT03226808
StatusCOMPLETED
Start Date2013-10-01
Completion2026-04-14
SponsorZimmer Biomet (INDUSTRY)
First posted
Last updated

Brief Summary

The objectives of this study are to obtain clinical performance (outcomes) data and survivorship for commercially available Vivacit-E (HXPE) liners. This will be done by analysis of polyethylene wear, validated outcome measurement tools, radiographs, and reported adverse events data.

Frequently Asked Questions

What is Vivacit-E Post-market Follow-up Study?

Vivacit-E Post-market Follow-up Study is a clinical trial registered under NCT03226808. Current status: COMPLETED.

What is the status of NCT03226808?

The current status of NCT03226808 (Vivacit-E Post-market Follow-up Study) is: COMPLETED.

When did Vivacit-E Post-market Follow-up Study start?

Vivacit-E Post-market Follow-up Study started on 2013-10-01.

Related Devices

K190660G7 Acetabular System Longevity Highly Crosslinked Polyethylene, G7 Acetabular System Vivacit-E Vitamin E Highly Crosslinked PolyethyleneZimmer, Inc. K243571Trabecular Metal Acetabular Revision System, Acetabular Liners and Constrained LinersZimmer Biomet K190656Dual Mobility - Longevity and Vivacit-E Polyethylene Hip BearingsZimmer, Inc. K212512G7® Vivacit-E® Freedom® Constrained LinerZimmer, Inc. K243293Zimmer® Persona® Personalized Knee SystemZimmer Biomet

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑